Prior Auth Required

0205U - neovascular age-related macular-degeneration risk associated with zinc supplements

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Serviceneovascular age-related macular-degeneration risk associated with zinc supplements
Procedure / Service Description

Ophthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 - Ophthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negative for 0205U neovascular age-related macular-degeneration risk associated with zinc supplements Neurology (Alzheimer disease); cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by ELISA,

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.